ICD-10-CM Billable Code

B02.21

Postherpetic geniculate ganglionitis

Clinical Classification Guidelines

Medical Intelligence & Overview

Postherpetic geniculate ganglionitis is a neurological condition that can occur after shingles, particularly affecting the facial nerve. Also known as a complication of herpes zoster, this condition involves inflammation of the geniculate ganglion — a collection of nerve cell bodies within the facial nerve. It can lead to various symptoms, primarily impacting facial movements and sensation, and may cause lasting discomfort if not managed properly.

Causes & Symptoms

Clinical Causes: Reactivation of the varicella-zoster virus, which causes shingles Inflammation and swelling of the geniculate ganglion following herpes zoster infection Immune response triggered by the viral reactivation leading to nerve damage Potential predisposition in older adults or immunocompromised individuals

Key Symptoms: Facial paralysis or weakness on one side (similar to Bell's palsy) Severe pain or burning sensation in the ear or face Facial tenderness or sensitivity Altered taste sensation on the anterior two-thirds of the tongue Hearing loss or tinnitus Dizziness or balance disturbances Persistent facial pain after the rash has healed

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a clinical examination focusing on neurological function and patient history, especially recent shingles episodes. Healthcare providers may employ imaging studies such as MRI scans to rule out other causes of facial paralysis. Electromyography (EMG) can assess nerve functionality, while laboratory tests might confirm recent herpes zoster infection through PCR or antibody detection. Accurate diagnosis is essential to distinguish this condition from other facial nerve disorders and to guide appropriate management.

Treatment Protocols: Management often includes medications aimed at reducing nerve inflammation and controlling pain. These may comprise antiviral drugs, corticosteroids, and pain relievers. Physical therapy might be recommended to improve facial muscle strength and prevent contractures. Early intervention is crucial to minimize complications such as persistent facial paralysis or chronic pain. Monitoring and supportive care are important components of treatment, tailored to individual patient needs.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is B02.21 a billable ICD-10 code?
Yes, B02.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report B02.21?
Clinical documentation must specify the nature of Postherpetic geniculate ganglionitis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

ganglionitis geniculate postherpetic